| 3.32 -0.02 (-0.6%) | 04-29 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.42  |
1-year : | 5.17 |
| Resists | First : | 3.78 |
Second : | 4.42 |
| Pivot price | 2.96 |
|||
| Supports | First : | 2.99 |
Second : | 2.5 |
| MAs | MA(5) : | 3.22 |
MA(20) : | 2.92 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 82 |
D(3) : | 87 |
| RSI | RSI(14): 58.6 |
|||
| 52-week | High : | 6.09 | Low : | 2.5 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ AMIX ] has closed below upper band by 9.8%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 3.79 - 3.81 | 3.81 - 3.83 |
| Low: | 3.28 - 3.3 | 3.3 - 3.31 |
| Close: | 3.29 - 3.32 | 3.32 - 3.34 |
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Mon, 08 Apr 2024
Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker - Yahoo Finance
Wed, 14 Feb 2024
Autonomix Medical, Inc. Reports Third Quarter FY2024 Financial Results and Reiterates Upcoming Key Milestones - Yahoo Finance
Tue, 13 Feb 2024
Autonomix Medical IPOs to the tune of $11.1M - InnovationMap
Tue, 30 Jan 2024
Autonomix Medical, Inc. Completes $8,000,000 Transaction - GlobeNewswire
Mon, 29 Jan 2024
Autonomix Medical, Inc. (NASDAQ: AMIX) Commences Trading on NASDAQ - GlobeNewswire
Fri, 26 Jan 2024
Autonomix Medical, Inc. Announces Closing of $11.2 Million in Gross Proceeds from Initial Public Offering - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 19 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 46.2 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 36 (K) |
| Shares Short P.Month | 8 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -5 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | -12.54 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|